Resources Blog Antibody Stability: Challenges and Solutions for Biologics Development

Antibody Stability: Challenges and Solutions for Biologics Development

Biointron 2024-01-20 Read time: 2 mins
Stability tests. Image credit: DOI: 10.1016/j.biochi.2020.08.019; 10.1533/9781908818096.377

Ensuring antibody stability is crucial during antibody generation and utilization, as instability can lead to reduced yields, lower efficacy, harmful immune reactions, patient-associated complications, and limited or lost function when working in extreme conditions or during long-term storage.  

The main factors affecting stability are the antibody’s format, structure, state of aggregation, and susceptibility to proteases. There are several methods to monitor the retention of biological function, including ELISA, Western blotting and affinity analysis (e.g. SPR/Biacore), during and after production. Additionally, circular dichroism, nuclear magnetic resonance, and mass spectroscopy have been used to indicate stability in the past.1

To overcome these issues with stability, one should strive to: 

  • Eliminate or minimize proteolysis, fragmentation or aggregation during antibody production. 

  • Stabilize the antibody format at the molecular level through sequence or domain swapping, CDR grafting, insertion of additional disulfide(s), or other chemical modifications. 

  • Ensure the use of appropriate buffers, additives and excipients. 

  • Carefully consider storage conditions including container, temperature, and moisture. 

Stability directly impacts an antibody’s efficacy, safety, and shelf life, making it a critical aspect of biologics development. At Biointron, we are dedicated to accelerating antibody discovery, optimization, and production. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects. 


  1. Ma, H., Ó’Fágáin, C., & O’Kennedy, R. (2020). Antibody stability: A key to performance - Analysis, influences and improvement. Biochimie, 177, 213-225. 

Subscribe to our Blog

Recent Blog

Computational antibody methods schematic. DOI: 10.1093/bib/bbz095The development of therapeutic antibodies has been significantly enhanced by advancements in computational methods and artificial intelligence (AI). These technologies have streamlined the antibody discovery process, improving the abil

May 27, 2024

Welcometo Antibody Basics by Biointron,Part 8. In this episode, we’ll talk about therapeutics targeting cancer.What is cancer immunotherapy?Cancer immunotherapy leverages the body's immune system to fight cancer more selectively and effectively than traditional methods such as chemotherapy

May 24, 2024

The generation of an immune response to a vaccine. DOI: 10.1038/s41577-020-00479-7Vaccination is one of the most effective tools in preventing infectious diseases. At its core, the success of a vaccine hinges on its ability to induce a robust and lasting antibody response against a specific pathogen

May 22, 2024

Innovation orientation and goals for transforming CAR-T cell engineering. DOI: 10.1186/s13045-020-00910-5Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary cancer treatment in which engineered CARs redirect lymphocytes, typically T cells, to recognize and destroy cells expressing a sp

May 20, 2024

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.